Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus
Abstract Hepatitis B Virus (HBV) is a hepadnavirus that is the principal pathogen underlying viral liver disease in human populations. In this study, we describe the isolation and characterization of a fully human monoclonal antibody for HBV. This HuMab was isolated by a combinatorial screen of the...
Main Authors: | Saket Jhajharia, Fritz Lai, Heng Boon Low, Kiren Purushotorman, Bhuvaneshwari D/O Shunmuganathan, Conrad En Zuo Chan, Rachel Hammond, Hans-Jürgen Netter, Qingfeng Chen, Seng Gee Lim, Paul A. MacAry |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-022-00516-7 |
Similar Items
-
Defining neutralization and allostery by antibodies against COVID-19 variants
by: Tulsian, Nikhil Kumar, et al.
Published: (2024) -
Defining neutralization and allostery by antibodies against COVID-19 variants
by: Nikhil Kumar Tulsian, et al.
Published: (2023-11-01) -
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
by: Ki Hyun Bae, et al.
Published: (2024-02-01) -
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2
by: Gu, Yue, et al.
Published: (2024) -
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2
by: Yue Gu, et al.
Published: (2023-12-01)